120 related articles for article (PubMed ID: 2222781)
1. Increased platelet 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease.
Bonuccelli U; Piccini P; Marazziti D; Cassano GB; Muratorio A
J Neural Transm Park Dis Dement Sect; 1990; 2(2):139-47. PubMed ID: 2222781
[TBL] [Abstract][Full Text] [Related]
2. Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions.
Schneider LS; Severson JA; Chui HC; Pollock VE; Sloane RB; Fredrickson ER
Psychiatry Res; 1988 Sep; 25(3):311-22. PubMed ID: 2847206
[TBL] [Abstract][Full Text] [Related]
3. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.
Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ
Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.
Soto J; Ulibarri I; Jauregui JV; Ballesteros J; Meana JJ
J Psychiatr Res; 1999; 33(3):251-7. PubMed ID: 10367991
[TBL] [Abstract][Full Text] [Related]
5. Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease.
Muck-Seler D; Presecki P; Mimica N; Mustapic M; Pivac N; Babic A; Nedic G; Folnegovic-Smalc V
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1226-31. PubMed ID: 19602426
[TBL] [Abstract][Full Text] [Related]
6. Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia.
Suranyi-Cadotte BE; Gauthier S; Lafaille F; DeFlores S; Dam TV; Nair NP; Quirion R
Life Sci; 1985 Dec; 37(24):2305-11. PubMed ID: 2999549
[TBL] [Abstract][Full Text] [Related]
7. Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding.
Poirier MF; Galzin AM; Pimoule C; Schoemaker H; Le Quan Bui KH; Meyer P; Gay C; Loo H; Langer SZ
Psychopharmacology (Berl); 1988; 94(4):521-6. PubMed ID: 3131797
[TBL] [Abstract][Full Text] [Related]
8. Platelet markers in suicide attempters.
Marazziti D; Presta S; Silvestri S; Battistini A; Mosti L; Balestri C; Palego L; Conti L
Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):375-83. PubMed ID: 7624489
[TBL] [Abstract][Full Text] [Related]
9. Methodological issues in the preparation and assay of platelet 3H-imipramine binding.
Severson JA; Schneider LS; Fredrickson ER
Psychiatry Res; 1990 Jul; 33(1):19-29. PubMed ID: 1699244
[TBL] [Abstract][Full Text] [Related]
10. Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients.
Zellner M; Baureder M; Rappold E; Bugert P; Kotzailias N; Babeluk R; Baumgartner R; Attems J; Gerner C; Jellinger K; Roth E; Oehler R; Umlauf E
J Proteomics; 2012 Apr; 75(7):2080-92. PubMed ID: 22270014
[TBL] [Abstract][Full Text] [Related]
11. Relationship between seasonal patterns of platelet serotonin uptake and 3H-imipramine binding in depressed patients and normal controls.
Chicz-DeMet A; Reist C; DeMet EM
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):25-39. PubMed ID: 2008538
[TBL] [Abstract][Full Text] [Related]
12. Serotoninergic dysfunction in bipolar disorder.
Marazziti D; Lenzi A; Cassano GB
Pharmacopsychiatry; 1991 Sep; 24(5):164-7. PubMed ID: 1775521
[TBL] [Abstract][Full Text] [Related]
13. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria.
Hannah P; Adams D; Glover V; Sandler M
J Psychiatr Res; 1992 Jan; 26(1):69-75. PubMed ID: 1313874
[TBL] [Abstract][Full Text] [Related]
14. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
[TBL] [Abstract][Full Text] [Related]
15. Platelet imipramine binding in endogenous depressed patients and controls: relationship to platelet MAO and 5HT uptake during successful imipramine treatment.
Quintana J
Psychiatry Res; 1990 Sep; 33(3):229-42. PubMed ID: 2173840
[TBL] [Abstract][Full Text] [Related]
16. Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects.
Roggenbach J; Müller-Oerlinghausen B; Franke L; Uebelhack R; Blank S; Ahrens B
J Neural Transm (Vienna); 2007; 114(4):479-87. PubMed ID: 16988795
[TBL] [Abstract][Full Text] [Related]
17. Platelet 3H-imipramine binding and steroid hormones serum concentrations during the menstrual cycle.
Poirier MF; Benkelfat C; Galzin AM; Langer SZ
Psychopharmacology (Berl); 1986; 88(1):86-9. PubMed ID: 3080779
[TBL] [Abstract][Full Text] [Related]
18. Platelet [3H]paroxetine binding to 5-HT uptake sites in Alzheimer's disease.
Andersson A; Adolfsson R; Eriksson K; Marcusson J
Neurobiol Aging; 1991; 12(5):531-4. PubMed ID: 1837595
[TBL] [Abstract][Full Text] [Related]
19. 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.
Raisman R; Briley MS; Bouchami F; Sechter D; Zarifian E; Langer SZ
Psychopharmacology (Berl); 1982; 77(4):332-5. PubMed ID: 6813892
[TBL] [Abstract][Full Text] [Related]
20. Platelet serotonergic markers and aggressive behaviour in healthy subjects.
Castrogiovanni P; Capone MR; Maremmani I; Marazziti D
Neuropsychobiology; 1994; 29(3):105-7. PubMed ID: 8022528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
